Bibliographic Details
| Title: |
Survival advantage of bevacizumab rechallenge in recurrent ovarian cancer regardless of platinum sensitivity. |
| Authors: |
Ozberk U; Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey., Esen SA, Sekmek S, Seven I, Bal O, Algin E, Yucel S, Uncu D |
| Source: |
Anti-cancer drugs [Anticancer Drugs] 2026 Jul 01; Vol. 37 (6), pp. 359-365. Date of Electronic Publication: 2026 May 06. |
| Publication Type: |
Journal Article |
| Journal Info: |
Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9100823 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5741 (Electronic) Linking ISSN: 09594973 NLM ISO Abbreviation: Anticancer Drugs Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
